Related Experiment Videos
Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system
1Department of Endocrinology, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Japan.
Biochemical and Biophysical Research Communications
|May 29, 1997
Summary
Researchers developed a novel controllable gene expression system using a reverse tetracycline-regulated retroviral vector (RTRV). This system enables doxycycline-inducible gene expression in cultured and implanted cells, offering potential for gene therapy applications.
Area of Science:
- Molecular Biology
- Gene Therapy
- Retroviral Vectors
Background:
- Controllable gene expression is crucial for gene therapy.
- Existing systems often require complex delivery methods.
Purpose of the Study:
- To develop a novel retroviral vector system for doxycycline-inducible gene expression.
- To simplify the delivery of controllable genes to cells in vitro and in vivo.
Main Methods:
- Construction of an autoregulatory cassette containing the reverse tetracycline-regulated (rtTA) system, a drug selectable marker, and the gene of interest (GFP).
- Infection of 208F cells with the retroviral vector.
- FACS analysis to quantify GFP expression.
- Oral administration of doxycycline (Dox) to nude mice with transplanted 208F cells.
Main Results:
- Significant induction of GFP fluorescence (two orders of magnitude) in infected cells, dependent on Dox concentration.
- Successful induction of GFP expression in transplanted cells in vivo following oral Dox administration.
- Demonstration of a simplified delivery of controllable genes.
Conclusions:
- The developed reverse tetracycline-regulated retroviral vector (RTRV) system enables efficient, controllable gene expression.
- This system simplifies gene delivery to both cultured and implanted cells.
- The RTRV system holds promise for controlled gene expression in gene therapy applications.